BRCA2 and ductal breast carcinoma in situ: While BRCA1 carriers predominantly present with high-grade hormone receptor-negative invasive breast cancer, BRCA2 mutation carriers have more luminal breast cancers and a higher proportion of DCIS, sometimes only detected as mammographic calcifications [10–12].